Onestep, I don’t know if you intended to repl
Post# of 148277
I don’t know if you intended to reply to someone else or if you somehow take my posts as negative.
NP has suffered from optimistic, forward looking communications that, when not fully realized, have been used against him. This seems to have improved.
I think he is doing well in a shifting environment, both with the fda and the landscape of Covid clinical care and the dependent trials.
I am fully invested and in support of Cytodyn. (Please see my mea culpa for abandoning rational investment, https://m.investorshangout.com/post/view?id=5920942).